-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
Blog
Enhancing Pharmaceutical Marketing: Proven Strategies for Engaging Healthcare Providers
Mar 07, 2023
In today's complex and rapidly evolving healthcare landscape, reaching and engaging healthcare providers (HCPs) has become a major challenge for the pharmaceutical industry. With a growing demand for personalized and seamless experiences, pharma companies are faced with the task of creating meaningful and impactful interactions with HCPs. To achieve this, the industry must adopt effective marketing strategies that are tailored to the unique needs and preferences of HCPs.
The pharmaceutical industry can take a data-driven, multi-channel, patient-centric, and educational approach to reach healthcare providers and build strong, collaborative relationships. By understanding the unique needs and preferences of HCPs, the industry can create more personalized and impactful marketing efforts, resulting in better outcomes for both HCPs and patients.
Understanding HCPs
HCPs are busy individuals who are inundated with information from a variety of sources. They depend on reliable and trustworthy sources to stay informed about the latest developments in their field and make decisions that impact their patients. To effectively reach and engage HCPs, it is crucial to understand their unique needs, preferences, and behaviors.
According to a recent study, 89% of HCPs prefer personalized interactions with pharmaceutical companies. HCPs value education and opportunities to stay up to date on the latest developments in their field, with 94% believing it is important for pharmaceutical companies to work with them to address their challenges and concerns. Additionally, 63% of HCPs use social media to access information related to their field, while 60% prefer to receive information from pharmaceutical companies through email.
Ways to More Effectively Market to HCPs
Data-Driven Approach
Utilizing data and analytics is key to creating targeted and personalized marketing efforts that resonate with HCPs. By gaining insights into HCP preferences, behaviors, and needs, the pharmaceutical industry can reach HCPs in a way that is tailored to their specific needs and preferences. This data-driven approach makes interactions with HCPs more meaningful and impactful.
By utilizing data, pharmaceutical companies can analyze individual healthcare providers' preferences, behaviors, and prescribing patterns at scale. For example, they can identify which healthcare providers have a preference for a specific channel, patient demographics, and clinical characteristics. This enables companies to generate personalized recommendations for sales representatives to engage with each provider in a personalized manner delivering to them the most relevant clinical trial data, educational resources, or patient materials. By providing personalized and relevant information, they can increase the likelihood of successful sales conversations, improve healthcare providers' perceptions of their brand, and ultimately drive revenue growth.
Multi-Channel Marketing
HCPs use a variety of channels to access information and communicate with others in their field. By utilizing a multi-channel approach to marketing, the pharmaceutical industry can reach HCPs through their preferred channels and increase the likelihood of engagement as a first step. In addition, by leveraging artificial intelligence and machine learning to analyze large amounts of data, pharmaceutical companies can improve delivering the optimal sequence of channel engagement, driving better outcomes and ultimately improving patient care.
Patient-Centric Focus
HCPs make decisions based on what is best for their patients. By placing a patient-centric focus on marketing efforts and highlighting how a product or service can improve patient outcomes, the pharmaceutical industry can more effectively engage HCPs. This patient-centric approach also helps build trust and establish the pharma company as a valued partner in the HCP's efforts to improve patient outcomes.
Pharmaceutical companies can identify medically relevant patients who could benefit from their therapies but have not yet tried them. Then they can use this information to target the healthcare providers to follow up with those patients. By starting with this foundation, companies can then leverage AI/ML solutions to suggest the most effective way to engage those healthcare providers and successfully start patients on their therapies.
Education and Thought Leadership
Providing educational resources and thought leadership content is crucial for establishing the pharmaceutical industry as a trusted and valuable resource for HCPs. This helps build trust and establish the pharma company as a knowledgeable and credible partner.
Collaborative Relationships
Building collaborative relationships with HCPs is key to more effectively marketing to them. This requires the pharmaceutical industry to listen to HCPs' needs and preferences, and work with them to address their challenges and concerns. By collaborating with HCPs, the industry can create solutions that are tailored to their needs and help build trust and credibility.
Collaborative relationships are essential for building trust and credibility with HCPs. By staying ahead of the curve and taking a proactive approach to marketing, the industry can continue to build strong and impactful relationships with HCPs.
IQVIA Next Best – Recommendations Platform
Precision intelligence that targets effectively via the right channels at the right time to drive your HCP messages home.
Related solutions
Field Force Operations
Keep your field force focused and productive